FT. LAUDERDALE, Fla., March 17, 2008 (PRIME NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release fourth quarter and fiscal year 2007 financial results after market close on Monday, March 31, 2008. Maurice R. Ferre, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call starting at 4:30 pm EDT on the same day. The call will be concurrently webcast.
To listen to the conference call, please dial 877-397-0292 for domestic callers and 719-325-4908 for international callers approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the Investor Relations section of MAKO's website at www.makosurgical.com.
About MAKO Surgical Corp.
MAKO Surgical Corp. is a medical device company that markets its advanced robotic arm solution and implants for minimally invasive orthopedic knee procedures. The MAKO Tactile Guidance System(tm) (TGS(tm)) includes a surgeon-interactive tactile robotic arm platform that utilizes a robotic arm and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants through a minimal incision. This FDA-cleared TGS(tm) allows surgeons to provide a tissue-sparing, bone resurfacing procedure called MAKOplasty(r) to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than two hundred licensed or owned patent applications and patents relating to the areas of computer assisted surgery, haptics, robotics and implants.